Online Courses for Physician

A complete listing of currently available online programs is provided below. To access course materials and claim credit you must be registered and logged-in. Courses of interest must be selected and added to your FCMCME.org user account. Once selected course material links will be provided from within your individual User Record section of this website.

Sort by: Title | Newest
*Closing Vaccine-Preventable Disease Disparities: Improving Herpes Zoster Adult Immunization A National Medical Association (NMA) Program
Presented by: Sabrina R. Kendrick, M.D., FACP | Virginia A. Caine, M.D.
Effective Date: January 01, 2020
Expiration Date: December 31, 2020
Credits: 2.0
Format: Webinar
Fee: Free
18584

This infectious disease symposium was held the morning of Tuesday, July 30th 2019 in Honolulu, Hi as part of the Annual National Medical Association Conference.

This Infectious Diseases program will provide a wide-range look at infectious disease threats nationally and globally with a special focus on Herpes Zoster that emphasizes and keeps participants abreast of the latest developments including case-based lectures, pathophysiology and pathobiologic principles with clinical presentations regarding the burden, diagnosis, treatment, and prevention of the above disease.

Supported in part by educational grants or unrestricted donations from GlaxoSmithKlne

More than a Rash: Herpes Zoster Clinical Manifestations and Treatment and Its Impact on Racial and Ethnic Populations
Sabrina R. Kendrick, M.D., FACP
Assistant Professor of Medicine, Division of Infectious Diseases Department of Internal Medicine Rush Medical College Chicago, IL

Update on CDC Recommendations on Herpes Zoster Vaccines and Strategies to Promote Zoster Vaccination
Virginia A. Caine, M.D.
Associate Professor of Medicine Division of Infectious Diseases Department of Internal Medicine Indiana University School of Medicine Indianapolis, Indiana

Learning Objectives:
At the conclusion of this session, participants will:

  1. Know the latest emerging infectious disease threats nationally and globally
  2. Explain the epidemiology of herpes zoster infection (HZ), typical and atypical clinical presentation, and diagnosis, and its impact on racial and ethnic populations
  3. Describe treatment interventions for acute HZ infection, including topical measures, use of antiviral agents, and pain management options.
  4. Discuss complications of HZ infection, including risk factors and prevention.
  5. Explain risks, benefits, contraindications, and other considerations for vaccination use to prevent HZ in at-risk adults.

Selection Required to Claim Credit

*Mitigating High Morbidity and Mortality Rates From Kidney Disease In At-Risk Patients A National Medical Association (NMA) Program
Presented by: Deidra C. Crews, MD, ScM, FASN, FACP | Akinlolu O. Ojo, MD, MPH, Ph.D., MBA | Ituno O. Owoyemi, MBBS | Winfred W. Williams, Jr., MD | Rasheed A. Balogun, MD, FACP FASN HP (ASCP)
Effective Date: January 01, 2020
Expiration Date: December 31, 2020
Credits: 3.0
Format: Webinar
Fee: Free
18634

This nephrology symposium was held the afternoon of Tuesday, July 30, 2019 in Honolulu, Hawaii. As part of the National Medical Association Annual Convention and Scientific Assembly.

Black and poor patients experience wider disparities related to the deterioration in kidney function which can occur in both acute and/or chronic stages and be responsible for considerable morbidity and mortality that often lead to a poor quality of life. Acute kidney injury (AKI) manifest along a continuum that can include chronic kidney disease (CKD), end-stage renal disease (ESRD), dialysis and transplantation which are all compelling indicator for high health services utilization, in-hospital morbidity and early mortality. Because of the complex comorbid conditions associated with AKI most patients are taking multiple prescriptions. Kidney disease has been described as the most neglected chronic diseases. The prevalence of CKD is 3.5 times higher in Blacks compared to Whites. The disparities exist at all stages of CKD. Importantly, Blacks are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure compared to Whites. The primary message for improving CKD outcomes are to develop and implement CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective medication treatments to control and/or eliminate CKD. ESRD affects Blacks more than any other ethnic group. Patients with ESRD must adhere to medication, diet, fluid restrictions, and dialysis treatment schedules if they do not receive a kidney transplant. An exploratory, study assessed adherence in 120 Blacks with ESRD undergoing hemodialysis (HD). Few participants (24%) adhered to dietary restrictions; however, fluid restriction was reported as the most difficult to manage, which was consistent with the interdialytic weight gain biomarker. Older participants were more adherent. Participants were adherent with HD attendance and medication. Disparities exists in US kidney transplantation. The persistent challenges of bridging healthcare disparities for Blacks in need of kidney transplantation continue to be unresolved at the national level. This session will explore and ways to address these challenges.

Supported in part by an educational grant from Sanofi Genzyme Corporation

Reducing Renal Disparities: Nephrology Workforce in US and Need for Increased Attention to Clinical Nephrology by Primary Care Physicians
Rasheed A. Balogun, M.D., FACP FASN HP (ASCP)
Professor of Medicine, University of Virginia School of Medicine, Medical Director, Apheresis Unit & Extracorporeal Therapies, Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia

Chronic Kidney Disease and Outcomes in African Americans
Deidra C Crews, MD, ScM, FASN, FACP
Associate Professor of Medicine, Division of Nephrology, Associate Director for Research Development, Center for Health Equity, Johns Hopkins University School of Medicine, Baltimore, Maryland

Back to the Motherland: Human Heredity and Health in Africa (H3Africa). The Kidneys
Akinlolu O. Ojo, MD, MPH, Ph.D., MBA
Assoc Vice President for Clinical Research & Global Health Initiatives (Outgoing), Professor of Medicine and Professor of Public Health, University of Arizona.
Executive Dean (incoming), University of Kansas School of Medicine, Kansas City, KS

Effect of Income and Race on Outcomes Among Dialysis Patients in the United States
Deidra C Crews, MD, ScM, FASN, FACP
Associate Professor of Medicine, Division of Nephrology, Associate Director for Research Development, Center for Health Equity, Johns Hopkins University School of Medicine, Baltimore, Maryland

Kidney Transplantation: Medications Options for Prophylaxis or Prevention of Acute Rejection in Patients
Itunu O. Owoyemi, MBBS
Certified Nephrologist, Transplant Nephrologist and Onconephrology Fellow, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

Kidney Transplantation in African Americans; Past, Present and Improving the Future
Winfred Woodrow Williams, Jr., MD.
Associate Chief, Division of Nephrology & Transplant Nephrologist, Transplant Center Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Learning Objectives:
At the conclusion of this session, participants will:

  1. List the stages chronic kidney disease
  2. List complications associated with Chronic Kidney Disease
  3. List methods used to identify chronic kidney disease CKD-MBD
  4. List poor outcome measures associated with uncontrolled CKD-MBD
  5. List treatment measures available to control CKD-MBD.
  6. List relevant medications used to treat Anemia of Chronic Kidney Disease and their indications
  7. List interventions to increase chances of successful pregnancies in patients with kidney disease and kidney transplants
  8. List common medication interactions in kidney transplant patients
  9. List strategies for prevention of kidney disease in living donors
  10. List health resources available for living donors
  11. List strategies that will lead to improved pregnancy outcomes.
  12. List immunosuppression safe in pregnancy after kidney transplantation
  13. List safe contraception for kidney transplant patients
  14. List teratogenic complications of transplant medications.

Selection Required to Claim Credit

Chronic Fatigue Syndrome and Hypothyroidism Are Linked To Low T3 Syndrome
Presented by: Neal Rouzier, MD
Effective Date: July 11, 2018
Expiration Date: July 11, 2020
Credits: 1.0
Format: Webinar
Fee: $30.00
17561

Dr. Rouzier, will be reviewing Chronic Fatigue Syndrome and how the signs and symptoms are similar, to hypothyroidism. How many times these conditions are misdiagnosed and how to interpret your patient's medical condition to improve clinical outcomes.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Review the work-up and diagnosis of Chronic Fatigue Syndrome.
  2. Recognize the many inflamed hormonal pathways in CFS.
  3. Discuss the pathophysiology involved in the development of CFS.
  4. Review thyroid lab tests as they pertain to CFS.
  5. Identify why it is called the hypometabolic syndrome.
  6. Review the studies that support normalizing TSH levels does NOT result in clinical euthyroidism.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Endobronchial Ultrasonography: A Practical Approach
Presented by: Gustavo Cumbo Nacheli, MD FCCP DAABIP | John Egan III, MD FCCP DAABIP
Effective Date: February 01, 2019
Expiration Date: January 31, 2021
Credits: 1.0
Format: Webinar
Fee: $15.00
17770

Society for Advanced Bronchoscopy (SAB) Archived Presentation January 2019

Often times first step on workup for intrathoracic abnormalities involve transthoracic sample acquisition. Understanding correct EBUS application and patient section are key to perform the correct procedure and expedites proper treatment.

At the conclusion of the webinar, the learner should have gained an enhanced understanding of intrathoracic lymph node anatomy, sampling techniques, and clinical usefulness of various endobronchial ultrasound guided diagnostic approaches; thereby improving patient outcomes.

Following the presentation questions from the audience were addressed in a moderated Q&A session.

Selection Required to View & Claim Credit

Heart Failure: What the Primary Care Provider Needs to Know for Better Patient Outcomes
Presented by: Peter J. Kudenchuk, MD
Effective Date: September 07, 2016
Expiration Date: September 06, 2020
Credits: 1.0
Format: Webinar
Fee: $10.00
16427

The goal of this course is to provide the knowledge and tools to equip the Primary Care Provider, Pharmacist and Other Health Care Providers to improve the health status of patients with Heart Failure. It includes an audience participated Q&A session and ends with a description of a 20 credit hour Performance Improvement Project and an invitation and instructions to enroll in this project without cost.

Outcome Objective
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. Distinguish heart failure with reduced left ventricular function from heart failure with preserved ventricular function.
  3. Explain the pathophysiological processes that occur to create clinical heart failure and promote its progression.
  4. Identify pharmacological and non-pharmacologic approaches to treating patients with heart failure and a step-wise approach to their implementation.
  5. Utilize the provider and patient toolkits to better educate patients about this condition and steps they can take to avoid it for better health outcomes.

Selection Required to View & Claim Credit

Nitric Oxide Therapeutic Intervention: Bridging the Gap Between Microvascular Dysfunction and Cognitive Impairment
Presented by: Nathan S. Bryan, Ph.D
Effective Date: September 01, 2019
Expiration Date: August 31, 2021
Credits: 1.0
Format: Webinar
Fee: $30.00
18000

In this presentation, Nathan S. Bryan will provide an overview of the atmospheric and human nitrogen cycles and nitric oxide production pathways in humans. He will review evidence based nitric oxide research specific to vascular function and structure. In addition to nitric oxide production, he will review the importance of nitrate and how much is recommended daily for health benefits. Dr. Bryan will also discuss nitric oxide therapeutic interventional outcome data and how to control and regulate nitric oxide production

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Recognize nitric oxide production pathways in humans.
  2. Demonstrate evidence on how NO affects vascular structure and function.
  3. Communicate evidence based nutritional strategies to restore and replete NO production in humans to restore vascular structure and function.

Selection Required to View & Claim Credit

Opioid Addiction: Challenging Cases in Diagnosis, Treatment, and Prevention
Presented by: Christine Mintz, MD
Effective Date: June 19, 2018
Expiration Date: June 19, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17283

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the pathophysiology of opioid receptors in the reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
  2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
  3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
  4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Reversal of Cognitive Decline: The Science, The Tools, and The Transformation
Presented by: Kenneth S. Sharlin, M.D., M.P.H., IFMCP
Effective Date: August 01, 2019
Expiration Date: August 01, 2021
Credits: 1.0
Format: Webinar
Fee: $30.00
17910

This presentation will address the burden of Alzheimer’s disease in the United States and the role of amyloid beta in the progression of this disease. You will be given the tools to help prevent Alzheimer’s disease through lifestyle medicine and modification.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Outline the burden of Alzheimer’s disease in the United States.
  2. Describe the role that the lipid-binding protein APoE4 plays in modifying the risk of Alzheimer’s disease.
  3. List at least two normal roles for amyloid beta in the brain.
  4. Describe the solutions lifestyle medicine provides to address the burden of Alzheimer’s disease.

Selection Required to View & Claim Credit